Breaking News

CordenPharma Colorado Enhances Lipid Purification Capacity

Announces another major capital expenditure initiative.

Author Image

By: Charlie Sternberg

Associate Editor

Due to the increasing demand since the beginning of the pandemic for mRNA Covid-19 vaccines formulated with Lipid NanoParticle (LNP) delivery systems, CordenPharma has been continuously investing in expanded lipid supply chain at our facilities in Switzerland, France and Colorado.   LNP delivery systems not only efficiently express the mRNA-encoded immunogen after intramuscular injection, but also play an important role as adjuvants in vaccine reactogenicity.   In order to accommodate this signi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters